2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Head & Neck
1
Endocrine
1
Classical hematology
1
CNS
1
Conditions
Brain Neoplasms
2310
Glioblastoma
2014
Glioma
1399
Central Nervous System Neoplasms
692
Astrocytoma
667
Neuroblastoma
647
Gliosarcoma
480
Neoplasms
405
Oligodendroglioma
404
Breast Neoplasms
327
Medulloblastoma
307
Carcinoma, Non-Small-Cell Lung
255
Meningioma
229
Recurrence
224
Sarcoma
214
Melanoma
206
Neoplasm Metastasis
202
Lung Neoplasms
199
Ependymoma
199
Neurofibromatosis 1
169
Lymphoma
161
Meningeal Carcinomatosis
138
Osteosarcoma
134
Ovarian Neoplasms
132
Wilms Tumor
123
Precursor Cell Lymphoblastic Leukemia-Lymphoma
123
Head and Neck Neoplasms
117
Lymphoma, Non-Hodgkin
116
Diffuse Intrinsic Pontine Glioma
113
Rhabdomyosarcoma
106
Interventions
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Tuberous Sclerosis 2
×
CNS
×
Clear all
NCT00790400
2017-02-17
EXIST-2
Novartis
Phase 3
Completed
118 enrolled
15 charts